BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 27, 2026
Home » Authors » Lynn Yoffee

Articles by Lynn Yoffee

Stents for PAD with a new twist: vascular magnetic intervention

April 20, 2010
By Lynn Yoffee

FDA clears Cambridge Heart's test for sudden cardiac arrest

April 19, 2010
By Lynn Yoffee

Panasonic to sell hearing aids to U.S. golden boomer market

April 16, 2010
By Lynn Yoffee
Jan. 1, 2011 will mark the era of the golden boomers, when they officially start to retire. This massive generation is getting older and along with that comes the decline of health, which presents opportunities for many companies to target with new product offerings. Consumer electronics giant Panasonic (Osaka, Japan) sees just such an opportunity to be part of that golden age and has decided to enter the hearing care business in the U.S. market. (Medical Device Daily)
Read More

Headset allows anesthesiologists to stay focused on the patients

April 15, 2010
By Lynn Yoffee

Supramap to aid in war against stealthy, evolving pathogens

April 14, 2010
By Lynn Yoffee

Sanuwave's dermaPACE in pivotal trial for foot ulcers

April 9, 2010
By Lynn Yoffee
Rather than treating a wound, Sanuwave Health's (Alpharetta, Georgia) dermaPACE technology harnesses the power of regenerative medicine to stimulate the body's own biological healing mechanism. With enrollment just completed in a pivotal phase III trial of dermaPACE to treat diabetic foot ulcers, the company is closer to launching a product that could address a $2 billion market in the U.S. and an estimated $10 billion advanced wound care market globally. (Medical Device Daily)
Read More

Improved device permits rapid review of circulating tumor cells

April 7, 2010
By Lynn Yoffee

Deals roundup: CareFusion buys Medegen for $225 million in cash

April 6, 2010
By Lynn Yoffee

Urovalve's Surinate bladder device aims to improve quality of life

April 5, 2010
By Lynn Yoffee

Product Briefs: DentalVibe brings good vibes to painful dental injections

April 1, 2010
By Lynn Yoffee
Previous 1 2 3 4 5 6 7 8 9 10 … 50 51 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 27, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Illustration of human face that looks abstract and digital

    AACR 2026: The age of agentic AI in oncology

    BioWorld Science
    New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
  • Chengdu Mfs Pharma synthesizes new compounds for pain

    BioWorld Science
    Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing